Description: DAE HWA Pharmaceutical Co., Ltd., a pharmaceutical company, produces and supplies pharmaceutical products in South Korea. The company offers skeletal muscle relaxants, gastrointestinal drugs, cardiovascular drugs, corticosteroids, antihistamines, vitamins and tonics, antibiotics, anti-inflammatory enzymes, analgesic and anti-inflammatory drugs liver diseases, antipyretics, plasters, cough suppressants, topical drugs, and other products, as well as drugs for liver diseases. It also provides transdermal drug delivery system, a pharmaceutical preparation that is applied to the intact skin for systemic absorption; and active pharmaceutical ingredients. The company also exports its products to approximately 22 countries, including Asia, South America, the Middle East, and Africa. DAE HWA Pharmaceutical Co., Ltd. was founded in 1984 and is headquartered in Seoul, South Korea.
Home Page: www.dhpharm.co.kr
2145, Nambusunhwan-ro
Seoul,
South Korea
Phone:
82 2 6716 1071
Officers
| Name | Title |
|---|---|
| Mr. Byung-Tae No | Chairman, CEO & Pres |
| Kim Eun-Seok | CEO & Director |
| Hye Youn Kim | Director of Devel. Department |
| Byung-Yoon Hwang | Head of Special Sales Division, Head Daegu Division and Sr. Managing Director |
| Je-Hyung Kim | Managing Director |
| Mr. Kwon-Suk Han | Sr. Managing Director |
| Young-Woo Cho | Managing Director |
| Jae-Kwon Yang | Head of Choongang Research Center and Director |
| Young-Taek Park | Head of Hyangnam Research Center and Director |
| Boon-Yeon Ahn | Head of Information System and Director |
Exchange: KQ
Country: KR : Korea (Republic of)
Currency: Korean Won (₩)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 1.5734 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |